Quantrx Biomedical Analysis

Quantrx Pink Sheet Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. Quantrx Biomedical had not issued any dividends in recent years. QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads and PAD based over-the-counter products in the United States. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon. Quantrx Biomedical is traded on OTC Exchange in the United States.The quote for Quantrx Biomedical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Quantrx Biomedical contact Shalom MD at 212 980 2235 or learn more at https://www.quantrx.com/index.htm.

Quantrx Biomedical Investment Alerts

Quantrx Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 605.96 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quantrx Biomedical's market, we take the total number of its shares issued and multiply it by Quantrx Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Quantrx Biomedical Outstanding Bonds

Quantrx Biomedical Debt to Cash Allocation

Quantrx Biomedical currently holds 2.77 M in liabilities. Debt can assist Quantrx Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Quantrx Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quantrx Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quantrx to invest in growth at high rates of return. When we think about Quantrx Biomedical's use of debt, we should always consider it together with cash and equity.

Quantrx Biomedical Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Quantrx Biomedical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Quantrx Biomedical, which in turn will lower the firm's financial flexibility.

Quantrx Biomedical Corporate Bonds Issued

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Quantrx Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Quantrx shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Quantrx Biomedical. By using and applying Quantrx Pink Sheet analysis, traders can create a robust methodology for identifying Quantrx entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

If you are still planning to invest in Quantrx Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quantrx Biomedical's history and understand the potential risks before investing.